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Albumin stimulates cell growth, L-arginine transport, and
metabolism to polyamines in human proximal tubular cells.
Background. Pure albumin stimulates proximal tubular ep-
ithelial cell (PTEC) proliferation, and may have a role in home-
ostasis in health, as well as in disrupted PTEC turnover in pro-
teinuric nephropathies. We investigated a role for arginine and
its metabolites, the polyamines, in this process, given the ability
of polyamines to trigger proliferation in other mammalian cells.
Methods. [3H]-L-arginine uptake was examined after incuba-
tion with 20 mg/mL recombinant human serum albumin (rHSA)
in HK-2 PTEC monolayers. Nitric oxide synthase (NOS) and
arginase activity was measured; NOS, arginase, and ornithine
decarboxylase (ODC) expression was identified by semi-
quantitative reverse transcription-polymerase chain reaction
(RT-PCR). Polyamine synthesis and intracellular amino acid
concentrations were compared using high-performance liquid
chromatography, and cell growth measured by [3H]-thymidine
incorporation.
Results. In HK-2 PTEC exposed to 20 mg/mL rHSA for
24 hours, cell proliferation as determined by [3H]-thymidine
incorporation was increased. In parallel, L-arginine transport
capacity was increased in a dose- and time-dependent man-
ner. This effect was specific to rHSA, and was not seen with
transferrin or immunoglobulin G. The intracellular concentra-
tion of L-arginine remained unchanged, although L-ornithine
was increased with rHSA incubation. rHSA up-regulated type
II arginase mRNA, and increased arginase activity, although
no difference in nitric oxide synthase expression or activ-
ity was seen. ODC mRNA was increased, as were intra-
cellular polyamine concentrations. a-Difluoromethylornithine
(DFMO), an ODC inhibitor, reduced intracellular polyamine
concentrations and rHSA-induced cell proliferation to control
levels.
Conclusion. The arginine-ornithine-polyamine pathway ap-
pears enhanced in PTEC incubated with rHSA and is involved
in cellular proliferation; this may offer novel approaches to un-
derstanding progressive proteinuric nephropathies.
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The proximal tubule efficiently absorbs intermedi-
ate molecular weight protein by a mechanism involving
megalin- and cubilin-assisted endocytosis. In health, fil-
tered albumin is absorbed with some returned to the
circulation intact, and some undergoing lysosomal degra-
dation [1]. Little intact albumin then appears in the urine,
although degradation fragments derived from albumin
are present in significant quantity [2, 3]. Measurable pro-
teinuria, a feature of glomerular injury, has been strongly
linked to disruption of normal tubulointerstitial architec-
ture and the progression of renal disease in numerous
clinical studies and animal models of protein overload
[4].
Albumin itself has been described as a survival fac-
tor within the kidney, scavenging potentially injurious
reactive oxygen species [5], and promoting proximal
tubular epithelial cell (PTEC) growth in vitro via a phos-
photidylinositol 3-kinase (PI 3-kinase)-related cascade
[6, 7]. Megalin-assisted albumin uptake also triggers in-
tracellular PTEC signaling through transcription factor
activation [8]. It is not clear how much albumin the prox-
imal tubule is exposed to in health: around 2 to 4 g/day
seems likely [4, 9], although as much as 400 g/day has been
reported recently [9, 10]. It is quite possible that albumin
uptake in health may contribute to tubular homeostasis
through its signaling capacity.
In models of proteinuric nephropathy, albumin causes
PTEC activation, generation of reactive oxygen species
[11], and activation of nuclear factor jB-dependent
proinflammatory genes [12–14]. The cytokines produced
through this process recruit inflammatory cells into the
tubulointerstitium and promote scarring. However, the
quantity and nature of reabsorbed albumin in such con-
ditions may be different to that found in health: fatty
acids bound to albumin aggravate injury [15, 16] via
a peroxisome proliferator activated receptor-c (PPAR-
c)-mediated pathway [17]. Albumin acts as a ‘Trojan
horse’ [18], bearing toxic fatty acids (and potentially
other bound moieties) into PTEC, with uncoupling of
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balanced cell turnover, contributing to PTEC dropout
with tubular atrophy and interstitial scarring. This expla-
nation goes some way to explaining the tension appar-
ent in the reported data on albumin’s action within the
proximal tubule—how it may act as survival factor, and
yet promote injury and the progression of renal disease,
depending on the concentration and nature of the albu-
min filtered. It may also offer an explanation as to why
renal outcomes in proteinuric nephropathies where albu-
min bears high fatty acid loads are so different to those
seen in minimal change nephropathy (with characteris-
tic highly selective proteinuria, and low albumin-bound
fatty acid burdens).
It is, thus, increasingly apparent that albumin has di-
verse and important effects on PTEC [19]. The mech-
anisms by which these effects are regulated within the
proximal tubule, depending on the nature and concen-
tration of albumin, and the conditions prevailing, is less
clear. The arginine-ornithine-polyamine pathway has the
potential to be involved in these interactions, although
it is little described in the kidney. L-arginine, a cationic
semiessential amino acid, and its metabolites mediate
multiple biological responses. An intermediate of the
urea cycle, it is a necessary precursor for the synthesis of
nitric oxide (NO), L-ornithine, polyamines, and L-proline
(Fig. 1). Although freely synthesized endogenously, many
cells require additional inwardly transported L-arginine
to support metabolic requirements, particularly if cell
homeostasis is disturbed. Trafficking of amino acids oc-
curs through a system of transmembrane transporters.
Cationic amino acids such as L-arginine enter cells via
specific transmembrane transporters, typically through
cationic amino acid transporters (CATs) facilitating (so-
called y+-like transport) [20]. In the normal proximal
tubule, with its unique absorptive role, both cationic and
neutral amino acid transport occurs through a system
of apical and basolateral glycoprotein associated trans-
porter protein heterodimers (so-called b0,+-like and y+L-
like amino acid transport). These transporters, acting in
concert, allow coupled, efficient transcellular uptake of
amino acids from the urinary space and into the intersti-
tium [21, 22].
Intracellular NO, synthesized from L-arginine, may
prove cytotoxic and cytostatic, particularly in high con-
centrations in response to cytokines. More modest con-
centrations are required for normal cell signaling and
function. A further L-arginine metabolite, L-ornithine,
may be utilized for the production of the polyamines (pu-
trescine, spermine, and spermidine) [23]. The polyamines
are important bivalent regulators of cell growth, capable
of increasing proliferation and differentiation in response
to certain signals, but also able to promote apoptosis.
Polyamines, and the rate-limiting steps involved in their
synthesis, have been implicated in the genesis of tumors,
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Fig. 1. L-arginine metabolic pathways. NOS, nitric oxide synthase;
ODC, ornithine decarboxylase; 1, spermidine synthase; 2, spermine syn-
thase.
in wound healing and repair, and in cellular resistance to
injury [24].
Given that albumin uptake influences PTEC turnover
and precipitates a complex signaling network involved
in growth and inflammation, we sought to describe the
transport of L-arginine in albumin-exposed proximal
tubular epithelial cells, examining the key arginine-
utilizing pathways in this model. The arginine-ornithine-
polyamine axis has been shown to have a pivotal role in
balanced cell turnover in a variety of tissues responding
to stressors, but little is known about this pathway in the
proximal tubule.
METHODS
Reagents and cell culture
All amino acids, acids, inhibitors, and other chem-
icals, including [2,3 3H]-L-arginine, [3H]-L-lysine and
[3H]-thymidine were obtained from Sigma-Aldrich Co
Ltd (Poole, Dorset, UK). a-Difluoromethylornithine
(DFMO) was from Merck Eurolab (Beeston, Notting-
ham, UK). RecombuminTM, an ultrapure recombinant
human albumin derived from Saccharomyces cerevisiae,
was obtained from Delta Biotechnology (Nottingham,
UK) as a 25% solution dissolved in NaCl buffer with
1.5 mg/100 mL Tween. The immortalized PTEC line HK-
2 [25] was cultured in a humidified atmosphere of 5%
CO2 in 95% air at 37◦C in Dulbecco’s modified Ea-
gle’s medium/Ham’s F-12, supplemented with 20 mmol/L
HEPES buffer, 2 lmol/L glutamine, 5% fetal calf serum
(Labtech International, Ringmer, East Sussex, UK), and
penicillin G 100 U/mL, amphotericin B 0.25 lg/mL,
and streptomycin 100 lg/mL. Fresh growth medium was
added to cells every 2 to 3 days until confluent. For
transport and proliferation studies, cells were cultured in
serum-free conditions for 24 hours prior to experimental
manipulation. In all experiments cells were stimulated
with recombinant human albumin (0.2 to 20 mg/mL) in
serum-free medium, or serum-free medium alone. All
media had comparable pH, and diluent alone in medium
did not reproduce the experimental effect of albumin.
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Amino acid uptake assays
Experimental medium was aspirated off prior to the
assay [26] being performed, and monolayers washed
in warmed Kreb’s buffer (NaCl, 119 mmol/L, KCl,
4.6 mmol/L, glucose, 11 mmol/L, CaCl2, 1.5 mmol/L,
MgCl2, 1.2 mmol/L, NaHCO3, 15 mmol/L, NaH2PO4,
1.2 mmol/L, and HEPES 25 mmol/L at pH 7.4). Cells
were then incubated at 37◦C for 30 minutes in Kreb’s
buffer containing 100 lmol/L L-arginine (to exclude any
immediate osmolar effect between experimental media).
In studies of sodium dependence, sodium was replaced
with potassium. Uptake media were prepared by adding
[3H]-L-arginine to Kreb’s buffer or sodium-free medium
at a final concentration of 0.5 to 1 lCi/mL. Uptake was
started by the addition of 0.2 mL of uptake medium,
and terminated by rapid removal, before washing three
times with an ice-cold stop solution containing 10 mmol/L
L-arginine. Uptake was linear for 7 minutes, and a time
point at 4 minutes was chosen for all experiments [27].
Nonspecific binding was assessed by measuring zero-
time uptake, which was achieved by adding medium,
immediately removing it, and stopping uptake. Cells
were lysed in 0.3 mL RIPA buffer (1% NP-40, 0.5%
w/v sodium deoxycholic acid, 0.1% SDS in AnalaRTM
grade water), and removed for liquid scintillation count-
ing in 2 mL EcoscintTM (National Diagnostics, Hull,
UK). Counting was performed in a LKB Wallac Rack-
beta (Turku, Finland) scintillation counter against appro-
priately quenched blanks. Inhibition was measured by
incubating 1 lmol/L [3H]-L-arginine in Kreb’s solution
with increasing concentrations of unlabelled L-arginine,
L-lysine, or L-leucine (0–1000 lmol/L), prepared and
mixed prior to uptake being measured. N-ethylmaleimide
(Sigma), a sulfhydryl reagent inhibitor of system y+-like
transport, was made up to 0.2 mmol/L in Kreb’s, and
preincubated at 37◦C for 10 minutes prior to [3H]-L-
arginine influx being measured. [3H]-L-lysine was used
to confirm that [3H]-L-arginine uptake was representa-
tive for cationic amino acid uptake in general. L-lysine
is more metabolically stable than L-arginine within cells,
and is useful to exclude transport assay artifact related to
L-arginine catabolism.
Arginine metabolism
In cell lysates, nitric oxide synthase activity was esti-
mated by measuring the conversion of [3H]-L-arginine to
[3H]-L-citrulline using a commercially available kit (Oxis
International, Portland, OR, USA). Arginase activity was
measured by a modified Schimke method [28]. Briefly,
cell lysates were incubated with 10 mmol/L MnCl2 in
Tris buffer (pH 7.5) at 55◦C for 10 minutes to optimize
arginase activity, then incubated at 37◦C for a further 60
minutes with excess L-arginine after mixing. The reac-
tion was terminated with 400 lL acid mixture to which
25 lL a-isonitrosopropiophenone was added, and incu-
bated for 45 minutes at 99◦C. After cooling in the dark for
10 minutes, urea generation as an index of arginase ac-
tivity was then measured spectrophotometrically against
a standard curve at 540 nm. All samples were measured
in duplicate with and without the activation step.
Polyamine synthesis
Polyamine synthesis was quantified using high-
performance liquid chromatography (HPLC) [29]. Cell
pellets were lysed in ice-cold 1 mol/L perchloric acid, and
1,6 hexanediamine was added as an internal standard.
Centrifuged supernatant was transferred into 2 mol/L
NaOH containing benzoyl chloride, and mixed gently in
glass tubes. Polyamines were then extracted in chloro-
form, mixed vigorously, centrifuged, and washed twice
in 0.1 mol/L NaOH to exclude benzoylated by-products.
The chloroform phase was evaporated and resuspended
in methanol, and the isocratic separation performed in
a 65:35% methanol/water mixture (for putrescine and
spermine) or a 60:40% methanol/water mixture (for sper-
mine). This was necessary to separate polyamine peaks
fused with benzoylated by-products. HPLC apparatus
comprised a 127 gradient solvent pump module and 166
UV/Vis variable wavelength detector from Beckman In-
struments (UK) Ltd. (High Wycombe, Bucks, UK). The
pump was connected to a manual RheodyneTM valve in-
jector (model 7725i) fitted with a 20-lL loop from Rheo-
dyne, Inc. (Cotati, CA, USA). Reversed phase AceTM C18
column (4.6 mm × 15 cm, 5-lm particle size) was from
Hichrom, Ltd. (Theale, Reading, UK). Peak area was
calculated by using a ChromJet integrator from Thermo
Separations Products (Stone Business Park, Stone, Staffs,
UK). Values were then normalized against the 1,6 hex-
anediamine internal standard, and quantified against
known standard concentrations of putrescine, spermine,
and spermidine, extracted by the same process.
Cell proliferation
Cell proliferation was measured using the [3H]-
thymidine incorporation assay. Monolayers at 70% con-
fluence in experimental media had 2 lCi [3H]-thymidine
added for the final 2 of 24 hours. Each well was then
washed five times in ice-cold DMEM-Ham’s F12, after
which 1 mL of ice-cold 5% v/v trichloracetic acid (TCA)
was added for 1 hour at 4◦C. TCA was then aspirated off,
and a further TCA wash performed. Thereafter, 2 mL
ice-cold ethanol with 200 lmol/L potassium acetate was
added for 5 minutes and removed. Two further 15-minute
incubations in 2 mL ethanol/ether (3:1 v/v) were per-
formed before the monolayers were dried in air and sol-
ubilized in 1 mL 0.1 mol/L NaOH. This was withdrawn
into scintillation vials, to which 3mL Ecoscint A (Na-
tional Diagnostics, UK) was added and counted in a beta
counter.
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RT-PCR
Total RNA was prepared from cells using RNeasy
minicolumns according to the manufacturer’s instruc-
tions (Qiagen, Hilden, Germany). mRNA was reverse
transcribed with oligo(dT) to first strand cDNA using
Superscript IIRT (Gibco BRL, Paisley, UK), again
according to the manufacturer’s instructions. Two lL
of resulting cDNA was used in each amplification
reaction under the following conditions: 20 mmol/L
Tris-HCl (pH 8.4), 50 mmol/L KCl, 2.5 mmol/L MgCl2,
0.25 mmol/L dNTP, 0.4 lmol/L each primer, 2.5 U Taq
DNA polymerase (MBI Fermentas, Vilnius, Lithuania).
Primers were obtained from MWG Biotech (Ebersberg,
Germany) as follows. Human arginase-I (330 bp) as
sense (5′-CTTGTTTCGGACTTGCTCGG-3′) and anti-
sense (5′-CACTCTATGTATGGGGGCTTA-3′) and
arginase-II (660 bp) as sense (5′-TCTATGACCAA-
CTTCCTACTC-3′) and antisense (5′-CTTCTGACTA-
CTCCCCACTT-3′) were initiated at 95◦C for 5 minutes,
then run for 35 cycles at 95◦C (60 seconds), 55◦C (60 sec-
onds), and 72◦C (60 seconds) prior to an extension step at
72◦C for 5 minutes [30]. Human ornithine decarboxylase
(636 bp) as sense (5′-CCTTCGTGCAGGCAATCTCT-
3′) and antisense (5′-GCTGCATGAGTT-CCCACGCA-
3′) was initiated for 5 minutes, then run for 35 cycles
at 93◦C (60 seconds), 57◦C (60 seconds), and 72◦C
(180 seconds), with a final extension step of 5 min-
utes [31]. Human type 2 NOS (658 bp) was as sense
(5′-AGACATCAACAACAATGTG-3′) and antisense
(5′-GACCTGCCGCCTGGAGAAAC-3′), and initiated
at 95◦C for two minutes, followed by 35 cycles of 95◦C (60
seconds), 58◦C (60 seconds), and 72◦C (60 seconds) [32].
For all PCRs, a Techne PHC-3 thermocycler (Techne,
Cambridge, UK) was used. After amplification, RT-PCR
products were separated on a 1% (wt/vol) agarose gel
containing 0.2 lg/mL ethidium bromide. Densitometry
was performed using Gel Blot Pro software (UVP
Systems, Ultraviolet Products, Ltd., UK).
Measurement of intracellular amino acids
After 24-hour incubation, monolayers were rapidly
washed in ice-cold Kreb’s solution three times, harvested,
and stored at −70◦C. HPLC coupled to fluorescence was
used to measure intracellular amino acid concentrations.
Amino acids were labeled with an active orthopthalalde-
hyde (OPA) reagent, prepared by treating OPA with ex-
cess 2-mercaptoethanol (2ME), forming an OPA-2ME
adduct. This adduct reacts with primary amines to form
a fluorescent isoindole, detected by a fluorescence detec-
tor (JASCO 4100, Great Dunmow, Essex, UK) with ex-
citation at 230 nm and emission at 440 nm with internal
standardization. Amino acid separation was performed
on a 3-octadecylsilane ultratachsphere column (75 mm
× 4.6 mm, HPLC Technology) maintained at a constant
temperature (22–24◦C). The mobile phase consisted of an
acetonitrile/methanol gradient. Data collection and area
integration was performed using a Gilson 715 HPLC sys-
tem (Anachem, Luton, UK).
Statistics
All data are represented as mean ± SD. Curve fitting
was performed by nonlinear regression using curve fitting
software (GraphPad PrismTM, San Diego, CA, USA).
Shapiro-Wilk testing was done to determine the distribu-
tion of data. Statistical analysis was generally performed
using one-way analysis of variance (ANOVA) with post-
hoc Bonferroni testing for multiple comparisons. If non-
parametric, Kruskal-Wallis ANOVA with appropriate
post-hoc testing was used. A P value of < 0.05 was ac-
cepted as significant.
RESULTS
Effect of rHSA on L-arginine transport
[3H]-L-arginine uptake was increased in HK-2 PTEC
exposed to 20 mg/mL rHSA compared to control (Fig. 2).
The kinetic parameters for uptake in control monolay-
ers showed an apparent Km of 64 ± 13 lmol/L and
an apparent Vmax of 401 ± 17 pmol/min/106 cells. In
rHSA-incubated monolayers, the apparent Km was 74 ±
14 lmol/L, and the apparent Vmax 628 ± 56 pmol/min/
106 cells (P = NS for Km, P < 0.01 for Vmax). In
HK-2 PTEC, 1 lmol/L [3H]-L-arginine uptake was in-
hibitable by competitive cationic and neutral amino acids.
Increasing concentrations of unlabelled L-arginine (0–
1000 lmol/L) or L-lysine (0–1000 lmol/L) readily inhib-
ited [3H]-L-arginine influx, with an inhibition constant
(Ki) of 17.3 lmol/L for L-arginine and 21.3 lmol/L for L-
lysine. The neutral amino acid L-leucine (0–1000 lmol/L)
inhibited uptake to a similar degree (Ki = 23.2 lmol/L).
Inhibition kinetics apparently suggest L-arginine influx
through the broad-scope cationic and neutral amino acid
transport systems b0,+ and y+L, as previously described
in PTEC [21]. Given that L-arginine influx has been previ-
ously described through the pure cationic amino acid sys-
tem y+-like transport in porcine PTEC [33] and tubular
preparations [27], HK-2 PTEC were preincubated with
0.2 mmol/L N-ethylmaleimide (NEM), a noncompetitive
and irreversible inhibitor of system y+-like transport. No
change in apparent Km or Vmax between NEM or con-
trol PTEC was observed. Monolayers exposed to rHSA
20 mg/mL had similar inhibition kinetic profiles to control
PTEC.
Apical exposure to increasing concentrations of rHSA
increased 50 lmol/L [3H]-L-arginine influx in a dose-
dependent (Fig. 3) and time-dependent (Fig. 4) manner,
significantly so at 20 mg/mL rHSA, and from 8 hours
exposure onward. This property of increased L-arginine
transport capacity appears specific to albumin in HK-2
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Fig. 2. [3H]-L-arginine transport capacity is increased by exposure to
albumin in PTEC. Significant increases in transport capacity were found
at all [3H]-L-arginine concentrations (N = 12, P < 0.05) with control
(open squares) and rHSA (closed squares) after 24 hours.
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Fig. 3. Apical rHSA increases 50 lmol/L [3H]-L-arginine transport ca-
pacity in a dose-dependent manner. Twenty-four–hour incubation with
increasing doses of rHSA (0.2–20 mg/mL) enhances 50 lmol/L [3H]-L-
arginine influx, significantly so at 20 mg/mL (N = 3, ∗P < 0.005).
PTEC, and was not seen with human iron-poor transfer-
rin or IgG (Fig. 5). The increase in [3H]-L-arginine up-
take was confirmed as being part of a general increase in
cationic amino acid uptake by using [3H]-L-lysine. [3H]-
L-lysine transport capacity was increased in HK-2 PTEC
incubated with 20 mg/mL rHSA. The kinetic parame-
ters for [3H]-L-lysine uptake showed an apparent Km of
62 lmol/L and an apparent Vmax of 283 pmol/min/106
cells. After 24 hours incubation with 20 mg/mL rHSA,
the apparent Km was 66 lmol/L, and the apparent Vmax
was 382 pmol/min/106 cells (N = 3, P < 0.01 for Vmax).
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Fig. 4. Apical rHSA 20 mg/mL increases 50 lmol/L [3H]-L-arginine
transport capacity in a time-dependent manner. Incubation with rHSA
20 mg/mL for 2 to 48 hours increased 50 lmol/L [3H]-L-arginine influx,
significantly so from 8 hours to a maximum at 24 hours (N = 4–5, ∗P <
0.05 at 8 hours, P < 0.01 at 16, 24, and 48 hours).
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Fig. 5. Increased 50 lmol/L [3H]-L-arginine transport capacity is spe-
cific to albumin. PTEC were incubated for 24 hours in control medium
or 10 mg/mL protein (rHSA, iron-poor human transferring, or human
IgG, N = 3, ∗P < 0.01 for rHSA against all other groups).
Effect of rHSA on intracellular and supernatant amino
acid concentrations
Neither intracellular nor supernatant L-arginine con-
centrations differed after 24 hours’ incubation with
rHSA 20 mg/mL compared to control (Fig. 6A).
Intracellular L-ornithine was found to be markedly
reduced in control HK-2 PTEC (in serum-free
conditions), although readily detectable in albumin-
incubated monolayers. Supernatant L-ornithine levels
were significantly increased in medium from rHSA
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Fig. 6. Intracellular and supernatant amino acid concentrations. (A)
After 24 hours’ incubation with apical rHSA 20 mg/mL, PTEC intra-
cellular L-arginine concentrations did not differ (N = 4, P = NS), but
L-ornithine concentrations were significantly different (<0.1 nmoL/106
cells, N = 4, ∗P < 0.05). (B) Medium withdrawn at the same time was
analyzed for the same amino acids. No difference was found between
supernatant L-arginine concentrations (L-arginine is displayed at 10−1
actual concentrations for illustrative purposes), but L-ornithine was
again significantly reduced in supernatant (N = 4, ∗P < 0.001).
exposed PTEC (45.5 ± 5.07 nmol/mL) compared to con-
trol (24.0 ± 0.82 nmol/mL, P < 0.05) (Fig. 6B).
Effect of rHSA on nitric oxide synthase activity
mRNA for type 2 NOS could be detected by RT-PCR
in HK-2 PTEC, but in very small quantities. No increase
in expression was detected after albumin exposure. Total
NOS activity after incubation with rHSA 20 mg/mL was
low as measured by L-citrulline generation (Fig. 7), and
did not differ significantly compared to control.
Effect of rHSA on arginase activity
Arginase activity after 24 hours as measured by urea
generation was significantly increased in HK-2 PTEC
monolayers exposed to rHSA 20 mg/mL (Fig. 8). One
mmol/L Nx-hydroxy-L-arginine (L-NOHA), an inhibitor
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Fig. 7. Apical albumin is not associated with altered L-arginine
metabolism by NO synthase. After 24 hours’ incubation with apical
rHSA 20 mg/mL, L-citrulline formation as a surrogate marker of nitric
oxide synthase activity in PTEC was unchanged (N = 4, P = NS).
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Fig. 8. Apical albumin is associated with increased L-arginine
metabolism by arginase. Arginase converts L-arginine to L-ornithine
and urea. Arginase activity was significantly increased with rHSA 20
mg/mL after 24 hours’ incubation (N = 6, ∗P < 0.05). rHSA 20 mg/mL,
when incubated with 1 mmol/L Nx-hydroxy-L-arginine (L-NOHA), an
inhibitor of arginase, reduced arginase activity to control levels (N = 4,
P = NS compared to control).
of arginase activity, reduced arginase activity to con-
trol levels. RT-PCR showed mRNA for both arginase
isoenzymes to be present in HK-2 PTEC. There was
no difference in the relative amount of type I arginase
mRNA in control and albumin-treated monolayers at 8 or
24 hours. However, the relative amount of type II arginase
mRNA (defined as arginase II mRNA/GAPDH mRNA
and quantified by relative optical densitometry) was sig-
nificantly increased at 8 hours, although not 24 hours with
albumin incubation (Fig. 9).
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Fig. 9. Arginase II mRNA is increased af-
ter apical albumin exposure at 8 hours.
Relative amount of mRNA quantitated by
densitometry and expressed as arginase II
mRNA/GAPDH mRNA ratio (N = 4, ∗P
< 0.01 for control against rHSA). Ethidium-
stained agarose electrophoresis gel show-
ing RT-PCR amplified arginase II and
glyceraldehydes-3-phosphate dehydrogenase
(GAPDH) cDNA from PTEC incubated in
control medium (lane 1), rHSA 20 mg/mL
(lane 2). Although arginase II mRNA was in-
creased at 24 hours, this did not achieve sig-
nificance.
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1 2* Fig. 10. Ornithine decarboxylase mRNA is
increased with apical albumin exposure at
24 hours. Relative amount of mRNA quan-
titated by densitometry and expressed as
ODC mRNA/GAPDH mRNA ratio (N = 4,
∗P < 0.05). Ethidium-stained agarose elec-
trophoresis gel showing RT-PCR amplified
ODC and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) cDNA from PTEC in-
cubated in control medium (lane 1) and rHSA
20 mg/mL (lane 2). Similar findings were
found at 8 hours.
Effect of rHSA on polyamines synthesis
L-ornithine is catabolized in a key rate-limiting step
by ornithine decarboxylase (ODC) to form putrescine,
in turn metabolized into spermidine and spermine. In
HK-2 PTEC cultured with 20 mg/mL rHSA, the rel-
ative amount of ODC mRNA was significantly in-
creased after 8 and 24 hours (Fig. 10, 24 hrs). All
intracellular polyamines were increased after 24 hours
by rHSA 20 mg/mL (although putrescine did not
achieve significance compared to control; Fig. 11). Co-
incubation with 1 mmol/L L-NOHA or 10 mmol/L
a-difluoromethylornithine (DFMO, an inhibitor of or-
nithine decarboxylase) substantially reduced polyamine
synthesis (Fig. 12).
Effect of rHSA on growth
HK-2 PTEC proliferated in response to 20 mg/mL
recombinant human albumin, as previously demon-
strated by Brunskill et al [6]. Proliferation was
shown to be dependent on polyamine synthesis. a-
Difluoromethylornithine (DFMO) was used to inhibit
ODC. After 24 hours’ coincubation with rHSA and
DFMO 0.1 to 10 mmol/L, [3H]-thymidine incorpora-
tion was returned to control levels in a dose-dependent
manner, significantly so for 1 mmol/L and 10 mmol/L
(Fig. 13A). DFMO was not toxic to HK-2 PTEC after
24 hours: no increase in lactate dehydrogenase release
was observed after 24 hours across this dose range (con-
trol LDH release = 100%, + DFMO 10 mmol/L 104 ±
13%, N = 6, P = NS), in keeping with previously re-
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Fig. 11. Apical albumin is associated with increased intracellular
polyamines. HPLC was used to compare intracellular putrescine, sper-
midine, and spermine in HK-2 PTEC exposed to rHSA 20 mg/mL for
24 hours (N = 4–8, ∗P < 0.05).
ported use of this inhibitor in the kidney [34, 35]. The
inhibitory effect of DFMO on rHSA-induced prolifera-
tion was in part reversed by the addition of the polyamine
putrescine (Fig. 13B). These findings were confirmed by
cell counting (data not shown). Equally, the arginase in-
hibitor L-NOHA (1 mmol/L) restricted proliferation to
control levels.
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DISCUSSION
This study describes an increase in apparent trans-
port capacity of the cationic amino acid L-arginine in
human HK-2 proximal tubular cells in response to pure
human albumin. This increase occurs through broad-
scope cationic and neutral amino acid transport systems,
and occurs in response to pure human albumin alone
in a time- and dose-dependent manner. This effect is
not seen with immunoglobulin or transferrin. Type II
arginase expression was increased after exposure to pure
human albumin, resulting in increased enzyme activity.
Intracellular and supernatant L-ornithine concentrations
increased in parallel. Nitric oxide synthase activity was
unchanged. Exposure to pure human albumin was associ-
ated with increased ornithine decarboxylase expression,
polyamine synthesis, and cell proliferation. Inhibition of
ODC prevented albumin-induced polyamine synthesis
and cell proliferation, an effect reversed in part by ad-
dition of exogenous polyamines.
The proximal tubule handles meaningful amounts of
albumin in health, with the glomerular filtration barrier
apparently more porous than first thought [36]. About
1.3 g/day of albumin-derived fragments appear in the
urine [2, 3], not detected by conventional assays. This
occurs in health without obvious proximal tubular toxi-
city. Albumin has a key role in PTEC signaling [8, 19].
Purified albumin was first described as a PTEC sur-
vival factor [5], scavenging injurious oxidants and act-
ing as a mitogen in vitro through a PI 3-kinase–mediated
pathway [6, 37]. However, in animal models of pro-
teinuria and in vitro, albumin induced PTEC apopto-
sis in excess of proliferation [17, 38]. This toxicity was
related to albumin-bound fatty acids, rather than albu-
min itself [15–17], offering a potential explanation for
a well-known clinical observation: minimal change dis-
ease, characterized by albuminuria with a low fatty acid
burden, rarely progresses to renal failure, unlike other
proteinuric nephropathies. A recombinant, lipid-free hu-
man albumin was, thus, used in this study, aiming to
isolate the effect of albumin on PTEC, and avoid the
confounding effect of bound moieties, particularly free
fatty acids.
The metabolites of L-arginine are involved in the reg-
ulation of cell proliferation in normal and inflamed tis-
sue, and in the growth of tumors. Increased L-arginine
transport capacity has been reported in vitro in other
proliferating nonrenal cell lines in response to growth
factors. In vascular smooth muscle cells, mitogens such as
angiotensin II, platelet-derived growth factor, and trans-
forming growth factor-b enhance cationic amino acid
transport [39–41], and with it, cell proliferation. This
study describes increased L-arginine transport in prolif-
erating PTEC exposed to pure albumin. In HK-2 PTEC,
the apparent cationic amino acid transport kinetic profile
for both unstimulated and rHSA-incubated cells is con-
sistent with the broad-scope cationic and neutral amino
acid transporter systems b0,+ and y+L. We (along with
other groups examining PTEC transport [42, 43]) could
not demonstrate evidence for system y+-like transport ac-
tivity in HK-2 PTEC, although this ubiquitous system has
been described in tubular suspensions in an animal model
of ischemic acute renal failure [27]. System y+ may be in-
ducible in this setting to account for particular L-arginine
needs—this is not the case after albumin exposure. Albu-
min is known to modify other transporter systems in the
proximal tubule, increasing sodium uptake and Na+/H+
exchanger expression and activity [44, 45]. Albumin may
thus affect a variety of physiologic processes in the kid-
ney.
In PTEC, intracellular L-arginine is abundant and
freely recycled from L-citrulline. Lysosomal degrada-
tion of endocytosed albumin may contribute further to
this pool. Why transport capacity should be further en-
hanced, when ambient concentrations exceed the Km
of most L-arginine utilizing enzymes at physiologic pH,
remains to be fully explained. L-arginine may be com-
partmentalized within the cytosol in PTEC, available to
distinct metabolic pathways in different circumstances.
This may result in increased cellular influx of L-arginine
into a specific ‘compartment’ and metabolic pathway.
This explanation for the so-called ‘arginine paradox’
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Fig. 13. rHSA-induced cellular proliferation
is inhibited by DFMO, an inhibitor of
polyamine synthesis, an effect in part re-
versed by coincubation with polyamines. Cel-
lular proliferation as [3H]-thymidine incorpo-
ration after 24 hours’ incubation with rHSA
20 mg/mL (where control was considered
100% proliferation). (A) rHSA significantly
increased [3H]-thymidine incorporation (N =
7, ∗P < 0.01 for rHSA compared to control),
an effect reversed by pre- and coincubation
with increasing doses of DFMO (N = 4–7,
∗P < 0.01 for control compared to rHSA and
rHSA + 0.1 mmol/L DFMO, no difference
compared to rHSA + 1 mmol/L or 10 mmol/L
DFMO). (B) Addition of the polyamine pu-
trescine 0.1 mmol/L to PTEC treated with
both rHSA and 10 mmol/L DFMO partially
restored albumin-induced proliferation (N =
4, ∗∗P < 0.05 vs. control).
applies most readily to cells with high L-arginine re-
quirements (such as for endothelial cells during sustained
NO synthesis), but is increasingly recognized in other
cell types. For example, in mesangial cells, simple L-
arginine supplementation is associated with TGF-b and
matrix protein expression and synthesis, and cell pro-
liferation [46], and in renal medullary cells, L-arginine
supplementation enhances NO synthesis and release
[47]. In metabolically active PTEC, compartmentaliza-
tion may permit L-arginine use from specific pools by
specific enzymes, directing signaling and effector path-
ways in cells stressed by excess protein absorption. In our
model, the albumin-induced increase in L-arginine trans-
port capacity did not affect intracellular or supernatant
L-arginine concentrations, suggesting its metabolism and
utilization.
Arginine may be hydrolyzed to L-ornithine and urea,
with L-ornithine then available for polyamine synthe-
sis (Fig. 1). Increased intracellular metabolism of L-
arginine to L-ornithine was found in rHSA-incubated
Ashman et al: Albumin stimulates cell growth to polyamines 1887
HK-2 PTEC. Total cellular arginase activity was in-
creased, with increased type II (though not type I)
arginase mRNA found by 8 hours after albumin expo-
sure. Of the two distinct mammalian arginase isoforms,
type I arginase is constitutively expressed in the cytosol
(and predominantly in the liver). Type II arginase is more
widely expressed (abundantly so in the kidney), and lo-
calized within the mitochondrial matrix. Mitochondrial
membrane L-ornithine transporters permit rapid equili-
bration of L-ornithine into the cytosol, then readily avail-
able for cytosolic utilization by ornithine decarboxylase
[48]. In proliferating cells, arginase II expression is usu-
ally increased in association with enhanced polyamine
production [49, 50]. With increased arginase activity,
L-ornithine was found in significantly higher intracel-
lular and supernatant concentrations. The combination
of increased L-arginine transport capacity and arginase-
induced metabolism to L-ornithine in response to growth
factors is a feature of many other proliferating mam-
malian cells, but has as yet not been described in PTEC
in response to albumin.
Decarboxylation of L-ornithine leads to the sequen-
tial synthesis of the polyamines putrescine, spermidine,
and spermine (Fig. 1). Polyamines are required for entry
into and progression within the cell cycle, and their syn-
thesis is one of the first events in cell proliferation [51,
52]. Polyamines may also be acquired from the extra-
cellular milieu through specific polyamine transporters.
In proximal tubular cells, polyamine availability is reg-
ulated by NO-related inhibition of ODC activity and
inward transmembrane polyamine transport [53]. In-
tracellular polyamine depletion inhibits cell growth: in
human embryonic kidney cells, overexpression of sper-
midine/spermine N-1-acetyl-transferase (SSAT) results
in polyamine catabolism, reduced spermidine and sper-
mine concentrations, inhibiting cell proliferation [54]. In
our experiments, a trend toward reduced NO forma-
tion was observed in parallel with an ODC-dependent
increase in the downstream polyamines spermidine and
spermine. Although polyamines may promote cell growth
and prevent cell death, they are also associated with cy-
totoxicity, and induce apoptosis with different environ-
mental signals. This usually occurs with high intracellular
concentrations or with oxidation to toxic aldehydes [24,
55]. As a result, intracellular polyamine levels are tightly
controlled. In human HK-2 cells, the increase in intracel-
lular polyamine concentrations is relatively modest after
exposure to pure human albumin (an established growth
factor). The cellular proliferation observed in HK-2 cells
occurs via a polyamine-dependent pathway, reversible
with DFMO inhibition of ODC, an effect partially re-
versed by the addition of putrescine to DFMO-treated
cells.
Intracellular L-arginine metabolites appear to be recip-
rocally regulated in human PTEC. When NOS activity is
induced (as found in acute inflammation), the arginine-
ornithine-polyamine pathway may be inhibited to favor
NO production. In proliferating PTEC, L-arginine is di-
rected is toward arginase and ODC, and away from NOS.
Proliferation in opossum PTEC exposed to pure albumin
has been well described by Dixon and Brunskill via phos-
photidylinositide 3-kinase (PI 3-kinase) activation and
the extracellular-signal related (ERK) family of MAP
kinases [6, 37]. We report here that human PTEC pro-
liferation in response to pure human albumin is in part
dependent on the synthesis of polyamines, with the con-
version of L-ornithine by ODC, a rate-limiting factor.
The mechanism by which polyamines regulate cell growth
is complex and multifactorial, and carefully controlled
within cells: how this regulation occurs is the subject of
ongoing work. It is intriguing to note that inhibition of
polyamine synthesis with DFMO in diabetic rats reduces
inappropriate renal growth [56], suggesting that this path-
way may be of importance in other disease models within
the kidney.
CONCLUSION
Clearly, the control of polyamine-induced prolifera-
tion, and the potential effects of exported polyamines on
neighboring cells, needs further investigation. The aim
of this study was to describe L-arginine transport capac-
ity and metabolism in proliferating human PTEC in re-
sponse purified human albumin. This model does not aim
to replicate models of PTEC injury associated with heavy
proteinuria and high albumin-bound fatty acid loads.
However, harnessing this knowledge, and comparing the
effect of modified albumin preparations on PTEC, may
reveal differences in regulation of the arginine-ornithine-
polyamine axis. This may offer novel therapeutic targets
in progressive, proteinuric nephropathies.
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